Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)
Identifiers
Identifiers
Services
Services
Date issued
2014Journal title
Hepatology
Type of content
Publicación de congreso
